Gut microbiota is involved in obesity,
metabolic syndrome and nonalcoholic fatty liver disease
(NAFLD). Strategies to modulate it, including faecal transplantation
and administration of prebiotics as quercetin, are actively
being examined. The present study aims to investigate benefits
of experimental gut microbiota transfer from donors to
germ-free mice (GFm) in a high-fat diet (HFD)-based NAFLD
model. Resumen de un trabajo resultado del proyecto de investigación financiado por la Consejería de Educación de la Junta de Castilla y León (referencia LE063U16)
